• Home
  • Search Results
  • Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.

Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.

Magnetic resonance in medicine (2013-09-06)
William T Triplett, Celine Baligand, Sean C Forbes, Rebecca J Willcocks, Donovan J Lott, Soren DeVos, Jim Pollaro, William D Rooney, H Lee Sweeney, Carsten G Bönnemann, Dah-Jyuu Wang, Krista Vandenborne, Glenn A Walter

The relationship between fat fractions (FFs) determined based on multiple TE, unipolar gradient echo images and (1) H magnetic resonance spectroscopy (MRS) was evaluated using different models for fat-water decomposition, signal-to-noise ratios, and excitation flip angles. A combination of single-voxel proton spectroscopy ((1) H-MRS) and gradient echo imaging was used to determine muscle FFs in both normal and dystrophic muscles. In order to cover a large range of FFs, the soleus and vastus lateralis muscles of 22 unaffected control subjects, 16 subjects with collagen VI deficiency (COL6), and 71 subjects with Duchenne muscular dystrophy (DMD) were studied. (1) H-MRS-based FF were corrected for the increased muscle (1) H2 O T1 and T2 values observed in dystrophic muscles. Excellent agreement was found between coregistered FFs derived from gradient echo images fit to a multipeak model with noise bias correction and the relaxation-corrected (1) H-MRS FFs (y = 0.93x + 0.003; R(2)  = 0.96) across the full range of FFs. Relaxation-corrected (1) H-MRS FFs and imaging-based FFs were significantly elevated (P < 0.01) in the muscles of COL6 and DMD subjects. FFs, T2 , and T1 were all sensitive to muscle involvement in dystrophic muscle. MRI offered an additional advantage over single-voxel spectroscopy in that the tissue heterogeneity in FFs could be readily determined.

Product Number
Product Description

Copper(II) sulfate, anhydrous, powder, ≥99.99% trace metals basis
Copper(II) sulfate, ReagentPlus®, ≥99%
Copper(II) sulfate, puriss. p.a., anhydrous, ≥99.0% (RT)
Copper(II) sulfate, puriss., meets analytical specification of Ph. Eur., BP, USP, anhydrous, 99-100.5% (based on anhydrous substance)

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.